XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income attributable to common shareholders $ 21.7 $ 37.8
Adjustments to reconcile net income to net cash flows provided by operating activities:    
Depreciation and amortization 21.6 18.5
Stock-based compensation expense 2.9 2.3
Deferred income taxes (0.5) 0.2
Cash used for operating working capital 61.4 50.8
Other (3.4) 1.5
Total (used for) provided by operating activities (19.1) 9.5
Investing activities:    
Capital expenditures (13.1) (12.5)
Payments for Derivative Instrument, Investing Activities (0.5)  
Settlement of forward contracts   0.0
Total used for investing activities (13.6) (12.5)
Financing activities:    
Dividends paid (9.7) (9.1)
Proceeds from stock options exercised 0.6 1.6
Payment of tax withholding on equity awards vested (5.6) (6.2)
Debt issuance costs (0.8) 0.0
Proceeds from revolving credit facility 106.0 30.0
Repayment of revolving credit facility (52.5) (5.0)
Repayment of term loan 0.0 (0.7)
Total provided by financing activities 38.0 10.6
Effect of exchange rates on cash, cash equivalents and restricted cash 6.7 (7.9)
Increase (decrease) in cash, cash equivalents and restricted cash 12.0 (0.3)
Cash, cash equivalents and restricted cash at beginning of period1 [1] 173.4 227.2
Cash, cash equivalents and restricted cash at end of period [2] 185.4 226.9
Current restricted cash 0.9 0.1
Noncurrent restricted cash 10.7 6.2
Detail of cash used for operating working capital:    
Accounts receivable 1.5 28.2
Inventories (9.8) (11.7)
Other current assets (5.0) (14.5)
Accounts payable (27.3) (16.3)
Accrued liabilities (11.5) (36.8)
U.S. and foreign taxes on income (9.3) 0.3
Supplemental disclosure of cash flow information:    
Interest paid 10.7 9.2
Income taxes paid 15.9 8.7
Unpaid capital expenditures $ 1.4 $ 2.0
[1] Includes both current and non-current balances of restricted cash. Current restricted cash, included within “Other current assets” in our Unaudited Condensed Consolidated Balance Sheets, was $0.8 million and $0.0 million as of December 31, 2024, and 2023, respectively. Non-current restricted cash, included within “Other assets” in our Unaudited Condensed Consolidated Balance Sheets, was $6.8 million and $0.0 million as of December 31, 2024, and 2023, respectively.
[2] Includes both current and non-current balances of restricted cash. Current restricted cash, included within “Other current assets” in our Unaudited Condensed Consolidated Balance Sheets, was $0.9 million and $0.1 million as of March 31, 2025, and 2024, respectively. Non-current restricted cash, included within “Other assets” in our Unaudited Condensed Consolidated Balance Sheets, was $10.7 million and $6.2 million as of March 31, 2025, and 2024, respectively.